If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jon Kroll Bjerregaard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
irinotecan Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Denmark Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2020

Prognostic impact of Charlson’s Age-Comorbidity Index and other risk factors in patients with pancreatic cancer

Bagni, K., Chen, I. M., Johansen, A. Z., Dehlendorff, C., Jensen, B. V., Hansen, C. P., Preus Hasselby, J., Holländer, N. H., Nissen, M., Bjerregaard, J. K., Pfeiffer, P., Yilmaz, M. K., Rasmussen, L. S., Nielsen, S. E. & Johansen, J. S., 6. Jan 2020, In : European Journal of Cancer Care. e13219.

Research output: Contribution to journalJournal articleResearchpeer-review

Pancreatic Neoplasms
Comorbidity
Smoking
Alcoholism
Confidence Intervals

Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer

Chen, I. M., Johansen, A. Z., Dehlendorff, C., Jensen, B. V., Bojesen, S. E., Pfeiffer, P., Bjerregaard, J. K., Nielsen, S. E., Andersen, F., Holländer, N. H., Yilmaz, M. K., Rasmussen, L. S. & Johansen, J. S., 1. Jan 2020, In : Cancer Epidemiology Biomarkers and Prevention. 29, 1, p. 176-184

Research output: Contribution to journalJournal articleResearchpeer-review

Pancreatic Neoplasms
Interleukin-6
Serum
Denmark
Hepatocytes

Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma

Bastholt, L., Schmidt, H., Bjerregaard, J. K., Herrstedt, J. & Svane, I. M., Sep 2019, In : European Journal of Cancer. 119, p. 122-131

Research output: Contribution to journalJournal articleResearchpeer-review

Melanoma
Population
Disease-Free Survival
Comorbidity
Multivariate Analysis

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

Bastholt, L., Svane, I. M., Bjerregaard, J. K., Herrstedt, J., Hróbjartsson, A. & Schmidt, H., 1. Jul 2019, In : European Journal of Cancer. 115, p. 61-67

Research output: Contribution to journalJournal articleResearchpeer-review

Interleukin-2
Melanoma
Disease-Free Survival
Databases
127 Downloads (Pure)
Open Access
File
Quality of Life
oxaliplatin
Cell Biology
Delivery of Health Care
Peritoneal Lavage

Activities 2007 2015

FOLFIRINOX for patients with LAPC

Jon Kroll Bjerregaard (Speaker)
20. Mar 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Nye kjemoterapiregimer til pasienter med lokalavansert og metastatisk pankreascancer. Marginale eller reelle forskjeller?

Jon Kroll Bjerregaard (Lecturer)
19. Apr 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Preoperative behandlingsstrategier for borderline og lokalavancert pankreascancer. Til hvem, når og hvilket regime er best?

Jon Kroll Bjerregaard (Lecturer)
19. Apr 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Forskningstræning Vestdanmark

Jon Kroll Bjerregaard (Participant)
5. Mar 20137. Mar 2013

Activity: Other activitiesOther